AI
AVDL

AdvisorShares Investments’s Avadel Pharmaceuticals AVDL Stock Holding History

AdvisorShares Investments’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,156
Closed -$382K – 266
2024
Q3 		$382K Sell
29,156
-1,865
-6% -$28.4K 0.07% 192
2024
Q2 		$438K Sell
31,021
-744
-2% -$12.1K 0.08% 168
2024
Q1 		$537K Buy
+31,765
New +$473K 0.09% 112

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return

AdvisorShares Investments's AVDL Position: Q4 2024 in Review

AdvisorShares Investments sold out of Avadel Pharmaceuticals (AVDL) in Q4 2024, closing a stake of 29,156 shares — an estimated $382K sold.

AdvisorShares Investments first reported a position in AVDL in Q1 2024 and held it in 3 quarters. The position peaked at $537K in Q1 2024. 159 funds tracked by Wall St. Rank hold AVDL as of Q4 2024.

  • AdvisorShares Investments reported no remaining Avadel Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • AdvisorShares Investments sold 29,156 Avadel Pharmaceuticals shares in Q4 2024, an estimated $382K.
  • AdvisorShares Investments first reported a position in Avadel Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • AdvisorShares Investments's Avadel Pharmaceuticals position peaked at $537K in Q1 2024.
  • 159 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2024.

Based on AdvisorShares Investments's 13F filing for Q4 2024, filed 14 Feb 2025.